Dr Reddys Laboratories (RDY) Gross Profit (2012 - 2026)

Dr Reddys Laboratories' Gross Profit history runs 15 years deep, the most recent figure standing at $368.6 million for Q1 2026.

• In Q1 2026, Gross Profit fell 32.47% year-over-year to $368.6 million; the TTM figure through Mar 2026 stood at $2.0 billion (down 10.85% YoY), while the FY2026 annual figure was $1.9 billion, down 15.29% from the prior year.
• Gross Profit was $368.6 million for Q1 2026 at Dr Reddys Laboratories, down from $525.6 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $581.0 million in Q4 2024 to a low of $467.18 in Q3 2022.
• Historically, Gross Profit has averaged $461.3 million across 5 years, with a median of $493.9 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Gross Profit plunged 100.0% in 2022, then soared 104527234.36% in 2023.
• A 5-year view of Gross Profit shows it stood at $439.0 million in 2022, then advanced by 15.46% to $506.9 million in 2023, then advanced by 14.62% to $581.0 million in 2024, then dropped by 9.53% to $525.6 million in 2025, then slipped by 29.88% to $368.6 million in 2026.
• The last three Gross Profit figures came in at $368.6 million (Q1 2026), $525.6 million (Q4 2025), and $568.2 million (Q2 2025), per Business Quant data.